ArticleEuropean journal of medicinal chemistry2023

Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization.

Miriam Girardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.